"The last thing you want to do is ignore a change... and then realize it is from an advanced cancer that could have been ...

In the UK NEOPRISM-CRC trial, 32 patients with stage II or III bowel cancer had no recurrences during 33 months of follow-up ...

Bengaluru: A group of Bengaluru doctors has found that a newer PET scan using a tracer called Fibroblast Activation Protein ...

On October 10, Akeso announced that the first patient had been dosed in COMPASSION-40, a Phase III study of cadonilimab as a ...

PET-CT is not routinely needed for every colon cancer patient, but it can help in selected cases by identifying suspected ...

Phase III trial of cadonilimab begins in perioperative colon cancer, testing dual PD-1/CTLA-4 blockade in MSI-H/dMMR patients ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1 ...

A Vancouver man diagnosed with colon cancer at 35 built his own screening test — and his story shows why younger Canadians ...

I’m never going to see them grow up,’” she said, tears falling from her eyes. “You just feel like you’re blaming yourself … ...

A father is taking on a challenging 60-mile walk in memory of his late son and to raise funds for the children's hospice that ...

Akeso, Inc. announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as ...